pharmaphorum

The dangerous risks of stopping Ozempic and GLP-1s

Alzheimer's disease starting to be considered a treatable condition

No more Nordisk as Novo goes it alone amid rebranding push

Got a migraine, acne or ear infection? Go to your chemist first

Alzheimer’s trial to test drug on people without symptoms to see if it can be prevented

'Fall From Grace'

Roche inks $1.53B deal for Simcere’s B-cell-targeting antibody

GSK plans phase 3 after mRNA flu vaccine beats standard shots

New heart attack definition promises better care for women

FDA Authorizes First Wearable Device to Continuously Monitor Glucose, Ketones

England set to eliminate hepatitis C

Multiple sclerosis: First drug to help patients walk now on NHS in England

14 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

Patients who suffer heart attack have more micro and nanoplastic in their blood

5 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

It’s not just Depo-Provera

Cancer cases worldwide will soar in the coming decades, a report finds. Here’s why.

A new global report warns of a significant surge in cancer cases worldwide over the coming decades.

Endometriosis could be diagnosed by blood test, research suggests

4 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.

EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials

A US House committee has launched an investigation into drug trials conducted in China by major pharmaceutical companies, including Merck and AbbVie.